Tiotropium bromide in asthma patients: an alternative to inhaled long-acting beta-agonists?

1 Simpson CR Sheikh A. Trends in the epidemiology of asthma in England: a national study of 333,294 patients. J R Soc Med 2010; 103:98–106. doi:10.1258/jrsm.2009.090348

2 Levy ML Thomas M Small I Summary of the 2008 BTS/SIGN British Guideline on the Management of Asthma. Prim Care Respir J 2009; 18(Suppl 1):S1–16. doi:10.3132/pcrj.2008.00067

3 Bousquet J Ben-Joseph R Messonnier M A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clin Ther 2002; 24:1–20. doi:10.1016/S0149-2918(02)85002-0

4 Nelson HS Weiss ST Bleecker ER The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129:15–26. doi:10.1378/chest.129.1.15

5 Singh S Loke YK Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and metaanalysis. JAMA 2008; 300:1439–50. doi: 10.1001/jama.300.12.1439. Erratum in: JAMA 2009; 301:1227–30.

6 Celli B Decramer M Kesten S Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 100:434–50.